Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomalidomide for MPN-associated myelofibrosis with transfusion-dependent anemia
CTR20132070Phase 3Suspended
- Sponsor
- Tigermed
- Start
- Mar 2014
- Modality
- Molecular Glues → Targeted Protein Degraders (TPDs) → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pomalidomide in myelofibrosis (MF), sponsored by Tigermed. Started Mar 2014; status: suspended.
02
Drugs
pomalidomide
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on CTR20132070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132070.